Indication
Carbapenem-Resistant Enterobacteriaceae Infection
5 clinical trials
6 products
Clinical trial
Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae: a Double Blind Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-08-19
Product
Fecal microbiota transplantClinical trial
Precise Treatment of Ceftazidime-Avibactam in Patients With CRO Infections Under the Guidance of TDM and PPK ModelStatus: Not yet recruiting, Estimated PCD: 2026-09-01
Product
Ceftazidime AvibactamClinical trial
Evaluation of Ceftazidime-avibactam Plus Aztreonam in Patients Infected by MBL-producing Enterobacterales and CRISPR/Cas9-based Strategy for Curing Drug-resistant GenesStatus: Recruiting, Estimated PCD: 2025-01-31
Product
CAZ/AVI + AztreonamClinical trial
Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection:a Prospective, Open-label, Randomized Controlled, Multicenter Clinical TrialStatus: Recruiting, Estimated PCD: 2025-07-01
Product
ColistinClinical trial
Ceftazidime-Avibactam Versus Colistin in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections (AVI-ICU): A Non-Inferiority Randomized Clinical TrialStatus: Terminated, Estimated PCD: 2023-04-12
Product
Ceftazidime-avibactam